CAEME
Argentine industry association that produces policy analyses, public reports and educational content and promotes clinical research, pharmacovigilance, genomic surveillance/bioinformatics and health‑economics work to inform policymakers, health professionals and the public.
Industries
Nr. of Employees
small (1-50)
CAEME
Buenos Aires, Distrito Federal, Argentina, South America
Products
Informe Weber (report series)
A multi‑chapter public report series on the social and economic value of medicines and health innovation in Argentina and Latin America, covering innovation, economic contribution, health indicators and access to innovation.
Consensus and adhesion documents
Joint position and consensus documents produced with multiple medical societies addressing continuity of care and public‑health recommendations.
Informe Weber (report series)
A multi‑chapter public report series on the social and economic value of medicines and health innovation in Argentina and Latin America, covering innovation, economic contribution, health indicators and access to innovation.
Consensus and adhesion documents
Joint position and consensus documents produced with multiple medical societies addressing continuity of care and public‑health recommendations.
Services
Production and publication of multi‑chapter reports analyzing the economic and social value of medicines and innovation, including cost‑impact and employment analyses.
Educational articles and campaigns on vaccines, patient safety, infectious diseases and appropriate medicine use targeted at the public and health professionals.
Organization and promotion of events, innovation days and challenges to foster collaboration between industry, researchers and clinicians.
Compilation and dissemination of evidence summaries for priority disease areas to inform stakeholders and guide public discussion.
Production and publication of multi‑chapter reports analyzing the economic and social value of medicines and innovation, including cost‑impact and employment analyses.
Educational articles and campaigns on vaccines, patient safety, infectious diseases and appropriate medicine use targeted at the public and health professionals.
Organization and promotion of events, innovation days and challenges to foster collaboration between industry, researchers and clinicians.
Compilation and dissemination of evidence summaries for priority disease areas to inform stakeholders and guide public discussion.
Expertise Areas
- Clinical trial management and facilitation
- Pharmacovigilance and medication-safety surveillance
- Genomic surveillance and bioinformatics
- Epidemiological surveillance and public‑health analytics
Key Technologies
- Next-generation sequencing (NGS)
- Bioinformatics and genomic data analysis
- Epidemiological surveillance systems and indicators
- Health economic and cost‑impact modelling
News & Updates
Article addressing common misconceptions about vaccine safety, efficacy and use; references WHO and national societies.
Article describing the role of bioinformatics and sequencing in detecting variants and supporting genomic surveillance.
Article summarizing epidemiological evidence on dengue transmission, mosquito biology and the need for year‑round vector control.
Analysis of employment, workforce composition and programs among member companies, including statistics on workforce size, gender distribution and R&D employment.
Chapter overview discussing definitions of pharmaceutical innovation, stakeholders' perspectives and elements of value.
Chapter summarizing epidemiology, treatment evolution and public‑health implications of diabetes in Argentina and globally.
Article addressing common misconceptions about vaccine safety, efficacy and use; references WHO and national societies.
Article describing the role of bioinformatics and sequencing in detecting variants and supporting genomic surveillance.
Article summarizing epidemiological evidence on dengue transmission, mosquito biology and the need for year‑round vector control.
Analysis of employment, workforce composition and programs among member companies, including statistics on workforce size, gender distribution and R&D employment.
Chapter overview discussing definitions of pharmaceutical innovation, stakeholders' perspectives and elements of value.
Chapter summarizing epidemiology, treatment evolution and public‑health implications of diabetes in Argentina and globally.